arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Tectonic Therapeutic, Inc.

TECX
$30.92 ▲ +0.66 (+2.16%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
37 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

Tectonic Therapeutic, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $580.3M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -9.4%
FCF / Share $-0.98
Trailing P/E
Price / Book 2.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

37-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-25.24M
↓ -58.7%
FCF / Share Free cash flow per share
$-0.98
↓ -28.5%
Long-Term Debt Long-term obligations
$15.00M
— 0.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
23
Cash Quality
55

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters